Europe
GlaxoSmithKline denied reports that they were interested in acquiring Canada’s Aurinia Pharmaceuticals, although some reports claim they are preparing to bid.
As the world marks a grim milestone of 5 million COVID-19 deaths, public health officials are keeping a close watch on a substrain of the Delta variant.
Yet another busy week for clinical trial news. Here’s a look.
The life sciences industry continues to be one of the fastest growing industries in the world as the end of the year draws near.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Paris-based Sanofi reported its third-quarter finances, with most of its categories showing strong growth. However, not everything was rosy
Although the literature suggests this condition may affect 200 people globally, Williams and his team think the numbers are higher.
The deal was struck one month after GammaDelta dosed its first patient in a Phase I acute myeloid leukemia (AML) trial.
Cell and gene therapies are at an inflection point, as increasing quantities of clinical data highlight both their potential and their challenges.
Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.
PRESS RELEASES